Pharma & Life Sciences

In regulated science, the record matters as much as the result.

Our goal in this sector

Move regulated data reliably without breaking validation or traceability.

// 01 — State of Play

Where the
sector stands.

Life sciences organizations operate under validation regimes where a change to software is a documented event. That makes speed hard and makes bad architecture expensive: every workaround becomes a permanent, validated workaround.

The opportunity is in the seams — between lab instruments and LIMS, between trial systems and analysis, between quality events and manufacturing. Those integrations are where time and data integrity are lost today.

// 02 — The Shifts

What technology is changing right now.

The forces reshaping this industry — and why they turn into engineering problems.

Shift 01

Trials decentralized

Remote visits and wearable data collection widened the data sources a trial has to ingest and reconcile.

Shift 02

Labs generate more data than they can use

Instrument output has outgrown manual review; automated capture and analysis pipelines are now necessary.

Shift 03

Quality went digital

Deviations, CAPA, and change control moved from paper binders to systems with real workflow and analytics.

Shift 04

Manufacturing got connected

Batch records and process data are increasingly electronic, which makes release faster and audits less painful.

// 03 — Friction

Where it breaks today

  • Instrument data transcribed manually into a LIMS
  • Trial data reconciled across sponsor, CRO, and site systems
  • Deviations tracked in spreadsheets with no trend analysis
  • Batch records reviewed on paper line by line
  • Validation burden discouraging any change at all
// 04 — What We Build

Systems that fix it

Lab and instrument integration

Automated capture from instruments into LIMS or ELN with full traceability and no transcription.

Clinical data pipelines

Ingestion, reconciliation, and transformation across sponsor, CRO, and device data sources.

Quality and CAPA systems

Deviation, investigation, and change control workflow with trending that surfaces systemic issues.

Validation-aware architecture

Systems designed so routine changes stay inside a validated envelope instead of triggering full requalification.

// 05 — Ground Rules

How we engineer here

21 CFR Part 11

Electronic records and signatures require identity, audit trails, and controls that are designed in from the start.

GxP validation

Software changes require documented qualification. Architecture is chosen to minimize revalidation scope.

Data integrity (ALCOA+)

Records must be attributable, legible, contemporaneous, original, and accurate — enforced technically, not procedurally.

Subject privacy

Clinical data is pseudonymized and access-controlled, with re-identification tightly restricted.

// 06 — Glossary

The language of the sector

Plain-English definitions, so nobody has to pretend they know what an acronym means.

LIMS
Laboratory Information Management System — tracks samples, tests, and results.
ELN
Electronic Lab Notebook — the structured replacement for the paper lab notebook.
CAPA
Corrective And Preventive Action — the formal response to a quality event.
GxP
The family of good practice regulations covering manufacturing, laboratory, and clinical work.
eBR
Electronic Batch Record — the digital record of a production batch.
// 07 — Questions

Straight answers.

Do you work in validated environments?

Yes, and we design so that ordinary changes do not force expensive revalidation.

Can you integrate lab instruments?

Yes — eliminating manual transcription is usually the fastest integrity win available.

Do you handle Part 11 requirements?

Audit trails, signature controls, and access management are built in rather than added later.

Running one of these
operations?

Describe your setup to our AI Strategist and get an architecture sketch back in seconds — or go straight to a human.